Abstract
In search of an improved treatment of pruritic dermatoses, we have studied azelastine, a novel H1-receptor antagonist, during a 2-week treatment period, using a double-blind, placebo-controlled design. The potent H1-antagonist cetirizine was used for comparison. Symptoms were recorded daily by the patients on a diary card, using a 4-point scale. The same parameters and adverse events were evaluated at weekly intervals, and global improvement was evaluated at the end of treatment. In all 230 evaluable patients with moderate to severe itching, azelastine caused an overall significant improvement in comparison to placebo (P = 0.02), with significance also for pruritus (P = 0.01 after 1 week and P = 0.02 after 2 weeks). Both drugs reduced itching more effectively in urticaria than in atopic eczema. Azelastine was superior to cetirizine in reducing pruritus, whereas cetirizine caused a more marked reduction of whealing. Both drugs rarely caused fatigue and dry mouth, but taste perversion occurred only in azelastine-treated patients (9.7%) and headaches only with cetirizine (10.4%). Therefore, the two H1-blockers exert differential effects on pruritus verses whealing and a distinctive adverse events pattern. The data also underline t...Continue Reading
References
Oct 1, 1992·The Journal of Allergy and Clinical Immunology·F E Simons
Apr 1, 1992·Allergy·C F Wahlgren
Jan 1, 1991·International Archives of Allergy and Applied Immunology·G M WalshA B Kay
Aug 1, 1986·British Journal of Pharmacology·P J BarnesP W Ind
Nov 1, 1989·The British Journal of Dermatology·J Berth-Jones, R A Graham-Brown
Jul 1, 1988·The British Journal of Dermatology·L Juhlin, C Arendt
Jul 1, 1983·The Journal of Investigative Dermatology·M S PetersG J Gleich
Dec 1, 1993·Trends in Pharmacological Sciences·P J Barnes, I Adcock
Jan 1, 1995·Archives of Dermatological Research·N HaasB M Czarnetzki
May 1, 1994·The British Journal of Dermatology·T van JoostW A van Vloten
Aug 1, 1995·Experimental Dermatology·U LippertB M Czarnetzki
Citations
Jun 10, 2000·The British Journal of Dermatology·R RukwiedM Schmelz
Nov 13, 2004·Drugs·Thomas Christian RoosHarald Brost
Sep 1, 2005·Expert Review of Clinical Immunology·Bettina Wedi, Alexander Kapp
Dec 30, 2015·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Thomas WerfelUNKNOWN Association of Scientific Medical Societies of Germany
Jan 5, 2002·The Journal of Investigative Dermatology. Symposium Proceedings·H F Merk
Jan 23, 2015·The Journal of Investigative Dermatology·Antoinette I M van LaarhovenAndrea W M Evers
Sep 24, 2009·Allergy·T ZuberbierB Wedi
Feb 7, 2012·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Karsten WellerTorsten Zuberbier
Jul 19, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·J RingUNKNOWN Global Allergy and Asthma European Network (GA2LEN)
Apr 14, 2010·Allergy·J Buddenkotte, M Steinhoff
Jun 6, 2014·Allergy·T ZuberbierM Maurer
Nov 8, 2013·Expert Opinion on Pharmacotherapy·Michael MakrisTorsten Zuberbier
Jan 15, 2000·The Journal of Dermatology·C F Wahlgren
Nov 18, 2016·Drugs in R&D·Andy WolffColin Dawes
Apr 21, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·A WollenbergUNKNOWN European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allerg
Mar 2, 2013·The Cochrane Database of Systematic Reviews·Christian J ApfelbacherElke Weisshaar
Jan 23, 2019·The Cochrane Database of Systematic Reviews·Uwe MatterneChristian J Apfelbacher
Jan 27, 2006·Allergy·T ZuberbierB Wedi
Aug 26, 2006·International Archives of Allergy and Immunology·Sharon EladMeir Shalit
Jun 8, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·A WollenbergUNKNOWN European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allerg
Aug 23, 2016·The British Journal of Dermatology·H NankervisH C Williams
Jan 27, 2005·Drugs·Larry K Golightly, Leon S Greos